Jing (Meghan) Shan, M.D., Ph.D is a glaucoma physician-engineer who is developing AI tools to ameliorate wide-spread glaucoma screening and referrals for early treatment.
Glaucoma is a leading cause of blindness worldwide. Early diagnosis and intervention is key to preserving vision. Population wide screening of glaucoma is currently unattainable due to limited glaucoma care resources. The Shan lab thus aims to develop biomimetic AI architectures to empower accurate and scalable disease screening methods. The Shan lab is also interested in extracting information from medical images beyond what human experts may be able to recognize and using that information to improve glaucoma management.
Shan earned her M.D. from Harvard University and her Ph.D. in medical engineering and medical physics from Massachusetts Institute of Technology.